Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:188 (28 July), doi:10.1136/bmj.39210.582801.BE (published 1 June 2007)
Ronald H Gray, epidemiologist1, Fredrick Makumbi, statistician3, David Serwadda, infectious disease specialist4, Tom Lutalo, data manager3, Fred Nalugoda, director of field activities3, Pius Opendi, laboratory director3, Godfrey Kigozi, medical officer3, Steven J Reynolds, laboratory consultant5, Nelson K Sewankambo, dean of medicine6, Maria J Wawer, public health specialist2
1 Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD 21205, USA, 2 Johns Hopkins University, Bloomberg School of Public Health, Baltimore and Mailman School of Public Health, Columbia University, NY, USA, 3 Rakai Health Sciences Program, Uganda Virus Research Institute, Entebbe, Uganda, 4 Makerere University, Institute of Public Health, Kampala, Uganda, 5 National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Entebbe, Uganda, 6 School of Medicine, Makerere University, Uganda
Correspondence to: R H Gray rgray{at}jhsph.edu
Design Diagnostic test accuracy study.
Setting Rural Rakai, Uganda.
Participants 1517 males aged 15-49 screened for trials of circumcision for HIV prevention.
Main outcome measures Sensitivity, specificity, negative predictive values, and positive predictive values of an algorithm using three rapid tests for HIV, compared with the results of enzyme immunoassay and western blotting as the optimal methods.
Results Rapid test results were evaluated by enzyme immunoassay and western blotting. Sensitivity was 97.7%. Among 639 samples where the strength of positive bands was coded if the sample showed positivity for HIV, the algorithm had low specificity (94.1%) and a low positive predictive value (74.0%). Exclusion of 37 samples (5.8%) with a weak positive band improved the specificity (99.6%) and positive predictive value (97.7%).
Conclusion Weak positive bands on rapid tests for HIV should be confirmed by enzyme immunoassay and western blotting before disclosing the diagnosis. Programmes using rapid tests routinely should use standard serological assays for quality control.
Trial registration Clinical Trials NCT00425984 [ClinicalTrials.gov] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses